Two new Monash Institutes have been recently approved by the University Academic Board and Vice-Chancellor and President Professor Margaret Gardner AO.
The Monash Biomedicine Discovery Institute (BDI) to be led by Professor John Carroll and the Monash Institute of Cognitive and Clinical Neuroscience (ICCN) to be led by Professor Kim Cornish. Together, with the existing Australian Regenerative Medicine Institute (ARMI), they create a unique Discovery Research Precinct in the Faculty of Medicine, Nursing and Health Sciences.
Monash Biomedicine Discovery Institute (BDI): Discovery Programs in immunity and infection, cancer, development and stem cells, cardiovascular disease, metabolic disease and obesity, and neuroscience.
Monash Institute for Cognitive and Clinical Neurosciences (ICCN): Discovery and clinical translation programs in addiction science, attention and memory, and sleep.
These new institutes will facilitate the collaboration of our researchers and clinical partners to accelerate and coordinate the translation of scientific breakthroughs. Between them, the three Institutes have 150 research groups, 700 staff, nearly 400 PhD students and total revenue of $145 million, a scale and quality of research activities that is amongst the best in the world.
The Institutes will be outward facing and the new Discovery Programs will increase interactions with funding agencies, industry, government and philanthropy.
Further updates will be provided later in the year as we move to officially launch the two new institutes.
For more information, contact email@example.com or visit